A blockbuster legal battle between the FCA and eight insurers kicked off in the High Court yesterday over the insurers’ refusal to pay out business interruption claims to thousands of small firms.
Shares in Southampton-based drug maker Synairgen were trading as high as 240p yesterday – up from 36.5p on Friday – after bosses revealed a ‘game changing’ new treatment for coronavirus.
Italy and Sweden have signalled their interest in the project – which is a partnership between the MoD and companies such as BAE Systems, Rolls-Royce and the UK arm of Italian group Leonardo.
The decision by Astrazeneca chief executive Pascal Soriot (pictured) to place the pharma group’s resources behind the Oxford Jenner Institute’s vaccine is paying off brilliantly.
The All Party Parliamentary Group on Alternative Lending has warned the financial difficulties which the coronavirus crisis has caused will prompt a spike in illegal lending.
The Resolution Foundation think-tank, which is focused on improving the living standards for those on low to middle incomes, compared the months leading up to the crisis with the situation in May.
Hermes will take on around 1,500 new full-time staff, including workers at its Yorkshire head office, warehouse staff, and drivers. It will also create 9,000 opportunities for self-employed couriers.
Astrazeneca said human trials of the vaccine it is developing with Oxford University have showed promising results, while Synairgen revealed a potentially ‘game-changing’ treatment.
Complaints against the lender, which has been described as a ‘legal loan shark’ by MPs, have soared in the last year, costing it £126million in the 12 months to March 31.
The announcement comes after fellow British chains John Lewis and Boots have already shed thousands of staff in the wake of the pandemic.